Genelabs Technology (GNLB)

Company Overview
Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of pharmaceutical products to improve human health. It is developing Prestara (prasterone), an investigational drug for women with systemic lupus erythematosus. The company also pursues drug discovery of novel anti viral compounds for the treatment of hepatitis C virus infections and advances pre clinical development of compounds in this program. Its products in pre clinical stage include HCV NSSb Polymerase and HCV NSSa for the treatment of Hepatitis C virus infection. Genelabs Technologies, in partnership with Glaxosmithkline, is also developing HEV Vaccine for the prevention of disease ca...
read more


As of 01:14PM EDT July 30, 2014
$ N/A   N/A (N/A%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: N/A
52 Week High: N/A Bid (size): N/A
52 Week Low: N/A Ask (size): N/A


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 505 PENOBSCOT DR REDWOOD CITY CA 94063 6503969500
Mailing Address: 505 PENOBSCOT DR REDWOOD CITY CA 94063
Phone: 650-369-9500
Fax: 650-368-0709

Company Details:

Symbol: GNLB
SIC: 874443
State location: CA
Sector: -
State of Inc: CA
Employees: 76

Key executives:

Name Age Position


A bright day for Genelabs Technologies (NASDAQ: GNLB) October 30, 2008

Genelabs Technologies (NASDAQ: GNLB) jumped more than 420% in a single day. The company closed at just $0.23 yesterday and has risen to $1.20 in pre-market trading today. read more


Genelabs Technology (GNLB) MESSAGE BOARD

Post # Subject Re Name Date
1 Have you heard the latest news on the... 0
2 Here on this message board we are inviting... 0